Moderna's combo flu and Covid jab boosts protection

The Guardian June 10, 2024, 03:00 PM UTC

Summary: A clinical trial by Moderna shows a combined flu and Covid vaccine elicits higher immune responses than separate shots. Results from a phase 3 trial of 8,000 participants indicate increased protection against both diseases. Moderna aims to make the vaccine widely available next year. CEO Stéphane Bancel highlights the potential of combination vaccines in reducing respiratory virus burdens. Boots in England offers Pfizer-BioNTech jabs for £98.95 to customers aged 12 and over.

Full article

Article metrics
Significance4.6
Scale7.0
Magnitude8.0
Novelty6.0
Actionability5.0
Immediacy7.0
Positivity8.0
Probability9.0
Credibility8.0

Timeline:

  1. [4.5]
    Moderna's mRNA-1083 vaccine shows positive Phase III results (Clinical Trials Arena)
    1d

  2. [4.2]
    Moderna's 2-in-1 Covid-19 and flu vaccine offers superior protection (The Straits Times)
    2d

  3. [3.8]
    Moderna reports positive results for COVID-19/flu combo vaccine (PMLiVE)
    3d
    Source
  4. [4.5]
    Moderna's combo flu and Covid vaccine excels in trial (DAWN.com)
    3d

  5. [4.2]
    Moderna's 2-in-1 flu and COVID vaccine shows promise (Livescience.com)
    3d

  6. [4.2]
    Moderna's COVID-19/flu combo vaccine outperforms separate shots in trial (GMA News Online)
    3d

  7. [3.5]
    Moderna's combo flu and Covid vaccine excels in trial (RTE.ie)
    4d
    Source
  8. [3.8]
    Moderna's COVID-19/flu combo vaccine outperforms separate shots in trial (GMA News Online)
    4d
    Source